glp-1 eating disorder Agonist for Binge Disorder: Evidence and Safety Eating Disorder Therapy Vs. Ozempic

Calories are reduced protein remains high and training focuses on maintaining strength while gradually losing body fat

7 The mean weight and BMI at baseline were 104.8 kg and 38.0 kg/m 2 , respectively, and after 72 weeks, the weight loss rates in patients who received tirzepatide at doses of 5 mg, 10 mg, and 15 mg were 15%, 19.5%, and 20.9%, respectively, which were significantly higher than the 3.1% weight loss rate observed in patients who received placebo

doi: 10.1016/j.jdiacomp.2022.108188

The co-founder's credentials (Dr

Metabolism 161:156057 Scheen AJ (2025) GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies

For patients interested in GLP-1 medications specifically for type 2 diabetes rather than weight management, the path is often simpler